{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:07:52Z","timestamp":1784542072751,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jtcvsopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTCVS Open"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.xjon.2023.09.005","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T23:36:03Z","timestamp":1694648163000},"page":"977-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Extended pleurectomy\/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesothelioma"],"prefix":"10.1016","volume":"16","author":[{"given":"Kenichi","family":"Okubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Wakejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Seshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjon.2023.09.005_bib1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase II study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolmab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomized, open-label, phase 3 trail","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xjon.2023.09.005_bib3","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis","volume":"35","author":"Nelson","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib5","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0003-4975(96)01228-3","article-title":"Patterns of failure after trimodality therapy for malignant pleural mesothelioma","volume":"63","author":"Baldini","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.thorsurg.2004.06.006","article-title":"Patterns of failure following surgical resection for malignant pleural mesothelioma","volume":"14","author":"Janne","year":"2004","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.xjon.2023.09.005_bib8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.2005.04.6813","article-title":"Phase I to II study of pleurectomy\/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma","volume":"24","author":"Richards","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib9","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jtho.2018.04.032","article-title":"A phase I trial of surgical resection and intraoperative hyperthermic cisplatin and gemcitabine for pleural mesothelioma","volume":"13","author":"Burt","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib10","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2016.67.2675","article-title":"Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma","volume":"34","author":"Rinner","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jtho.2017.02.026","article-title":"Improved outcomes with modern lung-sparing trimodality therapy in patients with malignant pleural mesothelioma","volume":"12","author":"Shaikh","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2016.08.071","article-title":"Extended pleurectomy-decortication-based treatment for advanced stage epithelial mesothelioma yielding a median survival of nearly three years","volume":"103","author":"Friedberg","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jtcvs.2014.10.041","article-title":"Pleurectomy\/decortication, hyperthermic pleural lavage with povidone\u2013iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience","volume":"149","author":"Lang-Lazdunski","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0022-5223(99)70297-7","article-title":"Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study","volume":"117","author":"Ratto","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000227208","article-title":"A new device for treatment of pleural malignancies: intrapleural chemohyperthermia preliminary report","volume":"50","author":"Carry","year":"1993","journal-title":"Oncology"},{"key":"10.1016\/j.xjon.2023.09.005_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11748-015-0535-x","article-title":"Interim results of pleurectomy\/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy","volume":"63","author":"Ishibashi","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/BF01213317","article-title":"In\u00a0vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under the c\/t curve","volume":"121","author":"Kobayashi","year":"1995","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib18","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jtho.2019.04.029","article-title":"A proposed system toward standardizing surgical-base treatments for malignant pleural mesothelioma, from the Joint National Cancer Institute\u2013International Association for the Study of Lung Cancer\u2013Mesothelioma Applied Research Foundation taskforce","volume":"14","author":"Friedberg","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib19","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.1992.10.6.1001","article-title":"Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies","volume":"10","author":"Rusch","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/thoraxjnl-2021-218214","article-title":"Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systemic review","volume":"78","author":"Dawson","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.xjon.2023.09.005_bib21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtcvs.2012.12.037","article-title":"Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection","volume":"145","author":"Sugarbaker","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib22","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jtcvs.2020.05.033","article-title":"Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma","volume":"161","author":"Hod","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jso.23321","article-title":"Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies","volume":"107","author":"Ried","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00001813-200301000-00008","article-title":"Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma","volume":"14","author":"Van Ruth","year":"2003","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.xjon.2023.09.005_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1096-9098(199606)62:2<135::AID-JSO10>3.0.CO;2-7","article-title":"Pharmacokinetics of cis-diamminedichloroplatinum (II) given as low-dose and high-dose infusions","volume":"62","author":"Kurihara","year":"1996","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jjco\/28.3.168","article-title":"Pharmacokinetics of cisplatin in combined cisplatin and 5-fluorouracil therapy: a comparative study of three different schedules of cisplatin administration","volume":"28","author":"Ikeda","year":"1998","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.xjon.2023.09.005_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00280-004-0852-8","article-title":"Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients","volume":"55","author":"Urien","year":"2005","journal-title":"Cancer Chemother Pharmocol"},{"key":"10.1016\/j.xjon.2023.09.005_bib28","first-page":"2117","article-title":"Pharmacokinetics of cisplatin","volume":"32","author":"Sawada","year":"1983","journal-title":"Obstet Gynecol Pract"},{"key":"10.1016\/j.xjon.2023.09.005_bib29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archinte.168.9.987","article-title":"Long-term prognosis of acute kidney injury after acute myocardial infarction","volume":"168","author":"Parikh","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.xjon.2023.09.005_bib30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/ALN.0000000000000891","article-title":"Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients","volume":"123","author":"Kork","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.xjon.2023.09.005_bib31","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","article-title":"Cellular pathophysiology of ischemic acute kidney injury","volume":"121","author":"Bonventre","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.xjon.2023.09.005_bib32","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jtcvs.2017.10.070","article-title":"Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: a 10-year experience","volume":"155","author":"Amhrogi","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib33","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/SLA.0000000000004306","article-title":"Pleurectomy decortication in the treatment of malignant pleural mesothelioma: encouraging results and novel prognostic implications based on experiences in 355 consecutive patients","volume":"275","author":"Lapidot","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.xjon.2023.09.005_bib34","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.21037\/tlcr-22-199","article-title":"Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach","volume":"11","author":"Klotz","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.xjon.2023.09.005_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.21037\/tlcr.2018.07.05","article-title":"The eighth TNM classification for malignant pleural mesothelioma","volume":"7","author":"Berzenji","year":"2018","journal-title":"Transl Lung Cancer Res"}],"container-title":["JTCVS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266627362300270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266627362300270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:51:25Z","timestamp":1762980685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266627362300270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":35,"alternative-id":["S266627362300270X"],"URL":"https:\/\/doi.org\/10.1016\/j.xjon.2023.09.005","relation":{},"ISSN":["2666-2736"],"issn-type":[{"value":"2666-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended pleurectomy\/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"JTCVS Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjon.2023.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}]}}